Published in Fitness and Wellness Business Week, April 25th, 2007
Study 1: Fresh data on HIV/AIDS are presented in the report "The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery." In this recent study, researchers in Netherlands conducted a study "To explore pregnancy outcome in HIV-1-positive and HIV-negative women, and mother-to-child transmission (MTCT) according to mode of delivery under effective highly active antiretroviral therapy (HAART). Cohort of 143 pregnant HIV-1-infected women including a matched case-control study in a 2:1 ratio of controls...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.